Details for Patent: 9,907,751
Which drugs does patent 9,907,751 protect, and when does it expire?
Patent 9,907,751 protects GLOPERBA and is included in one NDA.
This patent has two patent family members in two countries.
Summary for Patent: 9,907,751
| Title: | Composition and method of use of colchicine oral liquid |
| Abstract: | Oral liquid colchicine formulations are described herein. Methods of using the oral liquid colchicine formulations are also provided. |
| Inventor(s): | Indu Muni, Naomi Vishnupad |
| Assignee: | Rxomeg Therapeutics LLC |
| Application Number: | US15/358,621 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,907,751 |
|
Patent Claim Types: see list of patent claims | Formulation; Compound; Dosage form; |
Drugs Protected by US Patent 9,907,751
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scilex Pharms | GLOPERBA | colchicine | SOLUTION;ORAL | 210942-001 | Jan 30, 2019 | RX | Yes | Yes | 9,907,751 | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,907,751
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 3426227 | ⤷ Start Trial | |||
| World Intellectual Property Organization (WIPO) | 2017156392 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
